Home ⟩ Insights

Insights

analyst-ratings

4 min read • April 9, 2025

Is Legal Weed In Trouble? Taxes, Oversupply And Hemp Threat Drove A $21-Billion Cut In Sales Estimates

13 min read • March 28, 2025

This Week In Cannabis: Gaetz’s Stock Rally, Major Policy Battles, Homeland Security’s Stance, Big Earnings And More

3 min read • March 27, 2025

Canopy Growth’s Future Hinges On US Cannabis Regulatory Shifts, Says Analyst, Issuing ‘Neutral’ Rating

13 min read • March 7, 2025

This Week In Cannabis: Snoop’s Beverage Empire, Earnings, M&A, International News And More

4 min read • December 10, 2024

The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns

4 min read • December 9, 2024

This Cannabis REIT Offers 13%+ Yield, Safer Returns Than Fed-Backed Bonds

3 min read • December 9, 2024

85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning – See Who’s Leading

3 min read • December 6, 2024

Europe Says Thanks But We’ll Do It Ourselves – Canada Leads In Raw Cannabis Exports, Not Oil

3 min read • December 5, 2024

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand

3 min read • December 5, 2024

Better Than The Bank: Weed Real Estate Investment Company’s 14% Yield Beats Traditional Savings

3 min read • December 4, 2024

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow

4 min read • December 4, 2024

Is MariMed A Safe Haven In The Wake Of Florida’s Cannabis Legalization Defeat?

Latest Headlines

13 min read • July 10, 2026

Interstate Cannabis Commerce Was Impossible for a Decade. Rescheduling Just Opened Three Doors.

3 min read • July 10, 2026

How Cannabis Retailers And Brands Can Grow Profits In Competitive Markets, Experts Weigh In

4 min read • July 10, 2026

Why The World’s Largest Cannabis Company Won’t Uplist Despite Federal Reform, According To CEO

5 min read • July 9, 2026

Green Horizons’ CEO: “If You Don’t Have A Strong Why, You’re Not Going To Make It In Cannabis”

3 min read • July 8, 2026

Cannabis Needs To Act Like Normal Business To Unlock Institutional Investment, Experts Agree

4 min read • July 8, 2026

The UK Has 60,000 Medical Cannabis Patients. It Still Needs Doctors To Prescribe It.

5 min read • July 7, 2026

Cannabis Founders Are Discovering A Tax-Efficient Exit—Without Selling Their Companies

3 min read • July 7, 2026

Inside the Hemp Industry’s Last-Ditch Plan to Stop Federal Restrictions

4 min read • July 6, 2026

DEA Rescheduling Hearing Continues with Testimony from Anti-Weed Group

4 min read • July 6, 2026

DOJ Defends Authority To Reschedule Cannabis, Rejects Claims Of Industry Harm

3 min read • July 6, 2026

Lawmakers Propose Alternatives To Federal Hemp Product Crackdown, Here’s What Industry Says

3 min read • July 5, 2026

What A Maryland County Race Reveals About Cannabis And The GOP

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.